Trial Profile
Study of hexaminolevulinate detecting chromosomal aberrations in histological healthy tissue
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Hexyl aminolevulinate (Primary)
- Indications Bladder cancer
- Focus Biomarker; Therapeutic Use
- 30 Jun 2016 New trial record